Cited by 193Mesenchymal stem cell researchNeonatal Respiratory Health ResearchTransplantation: Methods and Outcomes

Mesenchymal stem cell-based therapy of inflammatory lung diseases: current understanding and future perspectives

Open access
Harrell, C. Randall, Sadikot, Ruxana, Pascual, Jose, Fellabaum, Crissy, Jankovic, Marina Gazdic, Jovicic, Nemanja, Djonov, Valentin, Arsenijevic, Nebojsa +1 more·2019·Stem Cells International

Abstract

During acute or chronic lung injury, inappropriate immune response and/or aberrant repair process causes irreversible damage in lung tissue and most usually results in the development of fibrosis followed by decline in lung function. Inhaled corticosteroids and other anti-inflammatory drugs are very effective in patients with inflammatory lung disorders, but their long-term use is associated with severe side effects. Accordingly, new therapeutic agents that will attenuate ongoing inflammation and, at the same time, promote regeneration of injured alveolar epithelial cells are urgently needed. Mesenchymal stem cells (MSCs) are able to modulate proliferation, activation, and effector function of all immune cells that play an important role in the pathogenesis of acute and chronic inflammatory lung diseases. In addition to the suppression of lung-infiltrated immune cells, MSCs have potential to differentiate into alveolar epithelial cells in vitro and, accordingly, represent new players in cell-based therapy of inflammatory lung disorders. In this review article, we described molecular mechanisms involved in MSC-based therapy of acute and chronic pulmonary diseases and emphasized current knowledge and future perspectives related to the therapeutic application of MSCs in patients suffering from acute respiratory distress syndrome, pneumonia, asthma, chronic obstructive pulmonary diseases, and idiopathic pulmonary fibrosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2019/4236973

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several studies reported that MSC-derived exosomes efficiently suppressed detrimental immune response in inflamed tissues, and promoted the survival and regeneration of injured cells.

    “Several studies reported that MSC-derived exosomes efficiently suppressed detrimental immune response in inflamed tissues, and promoted the survival and regeneration of injured cells [[73], [74], [75]].”

    From Exosome-functionalized magnesium-organic framework-based scaffolds with osteogenic, angiogenic and anti-inflammatory properties for accelerated bone regeneration. (2022) · cites this paper as [73]

    Section 7 (page unavailable) reports that MSC-derived exosomes attenuated lung inflammation and enhanced endogenous lung repair, supporting the immune-response and regeneration portions of the claim. It does not report that exosomes promoted the survival of injured cells; Section 8 discusses survival of transplanted MSCs instead. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Research works printed but not linked: 1

  1. [24]Katzenstein A. L. Acute Lung Injury Patterns: Diffuse Alveolar Damage and Bronchitis Obliterans Organizing Pneumonia 2006 4th Edn Philadelphia Saunders Elsevier

Cited by

Sorted by citations

Authors
Harrell, C. R., Sadikot, R., Pascual, J., Fellabaum, C., Jankovic, M. G., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V.
Affiliations
  • Regenerative Processing Plant, LLC, 34176 UD Highway 19 N Palm Harbor, Palm Harbor, Florida, USA
  • Emory University (US)
  • Department of Genetics, Faculty of Medical Sciences, University of Kragujevac, Serbia
  • Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, 69 Svetozar Markovic Street, Kragujevac, Serbia
  • University of Bern (CH)
  • West Pasco Pulmonary Associates, 7545 Medical Dr, Hudson, Florida, USA
  • Institute of Anatomy, University of Bern, 2 Baltzerstrasse, Switzerland
Venue
Stem Cells International
Publisher
Wiley
Published
2019-05-02
Volume
2019
Pages
1-14
ISSN
  • 1687-966X (ISSN-L)
  • 1687-9678
OpenAlex
W2943233832
Cited by
193
References
126
Citations by year
2026: 3 · 2025: 14 · 2024: 18 · 2023: 22 · 2022: 37 · 2021: 58 · 2020: 34 · 2019: 7
FWCI
4.14
Type
journal article
Language
en
Open access
Locations
  • Stem Cells International (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • BORIS (University Library Bern) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Open Access CRIS of the University of Bern
Funders
  • University of Kragujevac (MP01/18, ON175103, ON175069, 16C197)
  • Serbian Ministry of Science (MP01/18, ON175103, ON175069, 16C197)
  • Novartis Foundation (MP01/18, ON175103, ON175069, 16C197)
Topics
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Neonatal Respiratory Health Research
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords
mesenchymal stem cells, cell therapy, inflammatory lung disease, pulmonary fibrosis, acute respiratory distress syndrome, pneumonia, asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, immunomodulation, lung injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review